Literature DB >> 18003478

Patterned optical activation of retinal ganglion cells.

Nairouz Farah1, Inna Reutsky, Shy Shoham.   

Abstract

Neuroprosthetic retinal interfaces depend upon the ability to bypass the damaged photoreceptor layer and directly activate populations of retinal ganglion cells (RGCs). To date, the preferred approach to this task largely relies on electrode array implants. We are currently pursuing two alternative methods for light-based direct activation of the RGCs. The first method is based on applying caged glutamate over the retina and uncaging it locally to obtain RGC excitation. The second method is to artificially cause RGCs to express Channelrhodopsin II (ChR2), a light-gated cation channel. In addition to being non-contact, optical techniques lend themselves relatively easily to a variety of technologies for achieving patterned stimulation with high temporal and spatial resolution. Using the Texas Instruments Digital Light Processing (DLP - DMD) technology, we have developed an optical stimulation system capable of controlled, large-scale, flexible stimulation of the retinal tissue with high temporal accuracy. In preliminary studies, we are performing patterned photo-stimulation experiments using samples of caged fluorescent probes and in rat retinas that were virally transfected with ChR2.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18003478     DOI: 10.1109/IEMBS.2007.4353812

Source DB:  PubMed          Journal:  Conf Proc IEEE Eng Med Biol Soc        ISSN: 1557-170X


  29 in total

1.  Bi-stable neural state switches.

Authors:  André Berndt; Ofer Yizhar; Lisa A Gunaydin; Peter Hegemann; Karl Deisseroth
Journal:  Nat Neurosci       Date:  2008-12-08       Impact factor: 24.884

2.  High-resolution optical control of spatiotemporal neuronal activity patterns in zebrafish using a digital micromirror device.

Authors:  Peixin Zhu; Otto Fajardo; Jennifer Shum; Yan-Ping Zhang Schärer; Rainer W Friedrich
Journal:  Nat Protoc       Date:  2012-06-28       Impact factor: 13.491

3.  Functional stability of retinal ganglion cells after degeneration-induced changes in synaptic input.

Authors:  David J Margolis; Gregory Newkirk; Thomas Euler; Peter B Detwiler
Journal:  J Neurosci       Date:  2008-06-18       Impact factor: 6.167

4.  Correlation-distortion based identification of Linear-Nonlinear-Poisson models.

Authors:  Michael Krumin; Avner Shimron; Shy Shoham
Journal:  J Comput Neurosci       Date:  2009-09-15       Impact factor: 1.621

5.  Probing the function of neuronal populations: combining micromirror-based optogenetic photostimulation with voltage-sensitive dye imaging.

Authors:  Sachiko Tsuda; Michelle Z L Kee; Catarina Cunha; Jinsook Kim; Ping Yan; Leslie M Loew; George J Augustine
Journal:  Neurosci Res       Date:  2012-12-17       Impact factor: 3.304

6.  Holographic photolysis for multiple cell stimulation in mouse hippocampal slices.

Authors:  Morad Zahid; Mateo Vélez-Fort; Eirini Papagiakoumou; Cathie Ventalon; María Cecilia Angulo; Valentina Emiliani
Journal:  PLoS One       Date:  2010-02-25       Impact factor: 3.240

7.  Retinal channelrhodopsin-2-mediated activity in vivo evaluated with manganese-enhanced magnetic resonance imaging.

Authors:  Elena Ivanova; Robin Roberts; David Bissig; Zhuo-Hua Pan; Bruce A Berkowitz
Journal:  Mol Vis       Date:  2010-06-09       Impact factor: 2.367

8.  Multivariate autoregressive modeling and granger causality analysis of multiple spike trains.

Authors:  Michael Krumin; Shy Shoham
Journal:  Comput Intell Neurosci       Date:  2010-04-29

9.  Lycium Barbarum Polysaccharides Protect Retina in rd1 Mice During Photoreceptor Degeneration.

Authors:  Feng Liu; Jia Zhang; Zongqin Xiang; Di Xu; Kwok-Fai So; Noga Vardi; Ying Xu
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-01-01       Impact factor: 4.799

10.  Evaluation of the adeno-associated virus mediated long-term expression of channelrhodopsin-2 in the mouse retina.

Authors:  Elena Ivanova; Zhuo-Hua Pan
Journal:  Mol Vis       Date:  2009-08-21       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.